Pathway Financial Advisers, LLC
Position in TMO — Thermo Fisher Scientific Inc.
CIK 2024152
AUBURN, IN
Position in TMO
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$795,658
+$56,889 QoQ
Shares Held
1,587
+5.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#1,538
of 2,606 holders
Holding Since
Dec 2022
13 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Pathway Financial Advisers, LLC holds $795,658 across 1 Diagnostics & Research name. TMO ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
This page
|
1,587 | $795,658 |
All Filings in TMO
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $795,658 | 1,587 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $738,769 | 1,503 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $929,437 | 1,604 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $796,887 | 1,643 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $604,946 | 1,492 | Shares | Sole | 2025-08-21 | |
| 2025-03-31 | $689,176 | 1,385 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $691,905 | 1,330 | Shares | Sole | 2025-01-30 | |
| 2024-06-30 | $801,850 | 1,450 | Shares | Sole | 2024-08-20 | |
| 2024-03-31 | $823,574 | 1,417 | Shares | Sole | 2024-05-29 | |
| 2023-12-31 | $902,873 | 1,701 | Shares | Sole | 2024-07-19 | |
| 2023-09-30 | $858,948 | 1,697 | Shares | Sole | 2024-07-19 | |
| 2023-03-31 | $965,395 | 1,675 | Shares | Sole | 2024-07-19 | |
| 2022-12-31 | $922,931 | 1,676 | Shares | Sole | 2024-07-19 | |
| No filing history on record for this holder in this stock. | ||||||